Steve Nissen

Type: Person
Name: Steve Nissen
First reported Mar 25 2014 - Updated Mar 26 2014 - 1 reports

FDA Reviewers Recommend Against Approval For Novartis Heart Failure Drug

Ahead of an important advisory panel FDA reviewers have recommended against approval of a novel drug for acute heart failure from Novartis . The once highly-promising drug, which  received a ”breakthrough therapy” designation  from the FDA last year, ... [Published - Mar 25 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Millions more would get statins based on new guidelines

Just under half of all people ages 40-75 would be eligible for statin drugs under new guidelines designed to help doctors prescribe the cholesterol-lowering therapies.A study published Wednesday by the New England Journal of Medicine found that the guidelines, ... [Published - Mar 20 2014]

More Content

All (3) | News (3) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
FDA Reviewers Recommend Against Approval For No... [Published - Mar 25 2014]
Millions more would get statins based on new gu... [Published - Mar 20 2014]
Belviq's Battle of the Bulge [Published Pharmaceutical Executive - Oct 24 2013]
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.